应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09995 荣昌生物
休市中 03-20 16:08:48
93.200
-2.100
-2.20%
最高
99.650
最低
91.000
成交量
472.40万
今开
95.350
昨收
95.300
日振幅
9.08%
总市值
525.28亿
流通市值
194.40亿
总股本
5.64亿
成交额
4.46亿
换手率
2.26%
流通股本
2.09亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
【券商聚焦】中国银河:“十五五”首次将生物医药列为国家新兴支柱产业,持续发力研发创新
金吾财讯 · 03-20 09:23
【券商聚焦】中国银河:“十五五”首次将生物医药列为国家新兴支柱产业,持续发力研发创新
智通港股解盘 | 中东战事形势复杂扑朔迷离 科技股卷土重来带动人气
智通财经 · 03-18 20:19
智通港股解盘 | 中东战事形势复杂扑朔迷离 科技股卷土重来带动人气
港股异动 | 荣昌生物(09995)再涨近8% 维迪西妥单抗多项原创研究成果在2026 EAU集中发布
智通财经 · 03-18
港股异动 | 荣昌生物(09995)再涨近8% 维迪西妥单抗多项原创研究成果在2026 EAU集中发布
创新药概念震荡拉升 荣昌生物涨近7%创历史新高
每日经济新闻 · 03-17
创新药概念震荡拉升 荣昌生物涨近7%创历史新高
港股生物医药概念股走高,药明合联涨近7%,荣昌生物涨超5%
老虎资讯综合 · 03-17
港股生物医药概念股走高,药明合联涨近7%,荣昌生物涨超5%
荣昌生物公布国际专利申请:“抗Claudin18.2抗体药物偶联物用于治疗胃癌和/或胃食管结合部腺癌的用途”
证券之星 · 03-16
荣昌生物公布国际专利申请:“抗Claudin18.2抗体药物偶联物用于治疗胃癌和/或胃食管结合部腺癌的用途”
智通港股解盘 | 脑机接口概念再起 稳定币牌照发放在即
智通财经 · 03-13
智通港股解盘 | 脑机接口概念再起 稳定币牌照发放在即
港股异动 | 荣昌生物(09995)再涨超5% RC288注射液上市申请获受理 机构看好其全球潜力
智通财经 · 03-13
港股异动 | 荣昌生物(09995)再涨超5% RC288注射液上市申请获受理 机构看好其全球潜力
每日卖空追踪 | 荣昌生物 03月11日卖空量成交15.35万股,卖空比例为3.41%
市场透视 · 03-11
每日卖空追踪 | 荣昌生物 03月11日卖空量成交15.35万股,卖空比例为3.41%
3月10日荣昌生物涨10.27%,万家行业优选LOF基金重仓该股
证券之星 · 03-10
3月10日荣昌生物涨10.27%,万家行业优选LOF基金重仓该股
每日卖空追踪 | 荣昌生物 03月09日卖空量成交49.75万股,卖空比例为7.42%
市场透视 · 03-09
每日卖空追踪 | 荣昌生物 03月09日卖空量成交49.75万股,卖空比例为7.42%
荣昌生物盘中异动 股价大跌5.04%
市场透视 · 03-09
荣昌生物盘中异动 股价大跌5.04%
荣昌生物:PSMA/B7H3 ADC申报IND正心Ecosphere
动脉网 · 03-08
荣昌生物:PSMA/B7H3 ADC申报IND正心Ecosphere
港股异动 | 生物技术板块走强,药捷安康暴涨35%,百奥赛图涨14%
老虎资讯综合 · 03-06
港股异动 | 生物技术板块走强,药捷安康暴涨35%,百奥赛图涨14%
创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情
金吾财讯 · 03-06
创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情
港股异动 | 荣昌生物(09995)涨超6% 25年股东应占利润7.09亿元 机构料其现金储备显著增加
智通财经 · 03-06
港股异动 | 荣昌生物(09995)涨超6% 25年股东应占利润7.09亿元 机构料其现金储备显著增加
每日卖空追踪 | 荣昌生物 03月05日卖空量成交9.85万股,卖空比例为2.5%
市场透视 · 03-05
每日卖空追踪 | 荣昌生物 03月05日卖空量成交9.85万股,卖空比例为2.5%
荣昌生物(09995)2026年2月股份变动月报:股本维持不变
公告速递 · 03-04
荣昌生物(09995)2026年2月股份变动月报:股本维持不变
荣昌生物03月04日遭主力抛售133.5万元
市场透视 · 03-04
荣昌生物03月04日遭主力抛售133.5万元
中国Biotech,何时能盈利?
药通社 · 03-04
中国Biotech,何时能盈利?
加载更多
公司概况
公司名称:
荣昌生物
所属市场:
SEHK
上市日期:
--
主营业务:
荣昌生物制药(烟台)股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":93.2,"timestamp":1773994128008,"preClose":95.3,"halted":0,"volume":4724000,"delay":0,"changeRate":-0.022035676810073394,"floatShares":208581239,"shares":563608243,"eps":1.463456165231495,"marketStatus":"休市中","change":-2.1,"latestTime":"03-20 16:08:48","open":95.35,"high":99.65,"low":91,"amount":446395250,"amplitude":0.090766,"askPrice":93.2,"askSize":2000,"bidPrice":93,"bidSize":27500,"shortable":3,"etf":0,"ttmEps":-2.086275882062573,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":7,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":95.3,"openAndCloseTimeList":[[1773970200000,1773979200000],[1773982800000,1773993600000]],"volumeRatio":1.0601191696169143,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":116.73,"timestamp":1773990000000,"preClose":121.83,"halted":0,"volume":8207100,"delay":0,"premium":"-29.62"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"2620203185","title":"【券商聚焦】中国银河:“十五五”首次将生物医药列为国家新兴支柱产业,持续发力研发创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2620203185","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620203185?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:23","pubTimestamp":1773969824,"startTime":"0","endTime":"0","summary":"“十四五”规划重点关注医药创新产品产业化、医药产业化技术攻关、疫苗和短缺药品供应保障、产品质量升级、医药工业绿色低碳等五大工程,成效斐然,中国创新药获批上市数量由2015年的11款提升至2024年的92款,2024年共有22款国产化药和17款国产生物药获批上市,国产创新药占比提升至42%。“十五五”规划提出健全医疗、医保、医药协同发展和治理机制,生物医药产业首次被列为国家“新兴支柱产业”,战略定位进一步提升。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0540923850.HKD","BK0276","LU2778985437.USD","LU0307460666.USD","LU1720050803.USD","LU1770034418.SGD","LU0417516571.SGD","LU2476274308.USD","02162","02696","SG9999014674.SGD","BK1564","IE00B543WZ88.USD","LU0348767384.USD","601881","LU0052750758.USD","BK1141","LU0348825331.USD","161726","BK1588","BK4585","LU0348766576.USD","LU0588546209.SGD","LU2125910500.SGD","BK4581","LU0708995583.HKD","BK1161","06990","HK0000306701.USD","LU0196878994.USD","02359","BK4588","LU0348735423.USD","09926","HK0000306685.HKD","XBI","399441","LU0561508036.HKD","LU1969619763.USD","LU2242644610.SGD","02268","06881","LU2328871848.SGD","09995","LU2476274720.SGD","06160","BK1147","HK0000320223.HKD","LU2045819591.USD"],"gpt_icon":0},{"id":"2620558132","title":"智通港股解盘 | 中东战事形势复杂扑朔迷离 科技股卷土重来带动人气","url":"https://stock-news.laohu8.com/highlight/detail?id=2620558132","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620558132?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:19","pubTimestamp":1773836343,"startTime":"0","endTime":"0","summary":"估计内塔尼亚胡战略重点就是各种“斩首”行动为主。他提到中方对此表示接受。关于霍尔木兹海峡安全形势,外交部发言人毛宁此前在例行记者会上应询表示,维护霍尔木兹海峡及周边地区的安全稳定符合国际社会的共同利益。若无重大变化,三星电子工会成员将于5月21日至6月7日全面罢工。市场共识是面对着中东战事引发的高度不确定性,美联储本周将只能选择按兵不动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1134","BK1613","BK1522","02038","09995","BK1170","XLK","BK4588","01072","BK1167","BK1574","BK1508","VXUS","BK1583","LU2328871848.SGD","BK1205","LU1969619763.USD","LU0348766576.USD","BK1147","03086","BK4585","LU0348767384.USD","VGT","SG9999001069.SGD","TTTN","BK1504","BK1161","03200","BK1546","06088","03896","BK1183"],"gpt_icon":1},{"id":"2620288926","title":"港股异动 | 荣昌生物(09995)再涨近8% 维迪西妥单抗多项原创研究成果在2026 EAU集中发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2620288926","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620288926?lang=zh_cn&edition=full","pubTime":"2026-03-18 10:13","pubTimestamp":1773799996,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,荣昌生物再涨近8%,截至发稿,涨6.08%,报96.8港元,成交额2.38亿港元。值得注意的是,荣昌生物近日发布业绩快报,营业收入32.51亿元人民币,同比增加89.36%;归母净利润7.09亿元,同比扭亏为盈。营业收入增加主要是由于注射用泰它西普和注射用维迪西妥单抗销量增加,销售收入增加;此外,公司授予Vor Biopharma Inc.泰它西普除大中华区以外全球范围内的独家开发与商业化权利,技术授权收入大幅增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1161","LU2148510915.USD","LU1064130708.USD","LU1064131003.USD","VXUS","BK1574","09995","LU2488822045.USD","688331","BK4585","LU2328871848.SGD","LU1969619763.USD","BK4588","BK1583"],"gpt_icon":0},{"id":"2620414809","title":"创新药概念震荡拉升 荣昌生物涨近7%创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2620414809","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620414809?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:40","pubTimestamp":1773715209,"startTime":"0","endTime":"0","summary":"每经AI快讯,3月17日,创新药概念震荡拉升,荣昌生物涨近7%创历史新高,三生国健、苑东生物、悦康药业、君实生物、必贝特、益方生物跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603173674271269.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674271269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688331","LU2148510915.USD","09995","BK1574","159992","LU1064131003.USD","LU2488822045.USD","06978","BK1161","LU1969619763.USD","LU2328871848.SGD","BK1583","BK0239","LU1064130708.USD"],"gpt_icon":0},{"id":"1150046369","title":"港股生物医药概念股走高,药明合联涨近7%,荣昌生物涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150046369","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150046369?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:28","pubTimestamp":1773714505,"startTime":"0","endTime":"0","summary":"3月17日,$生物(000504)$医药概念股走高,$药明合联(02268)$涨近7%,$荣昌生物(09995)$涨超5%,$君实生物(01877)$、$诺诚健华(09969)$、$药明康德(02359)$等个股跟涨","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5f115a7e903cc298acc05fac997c6569","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU1969619763.USD","LU1064131003.USD","BK0239","BK1583","BK1161","09995","BK4581","LU2148510915.USD","02268","BK4588","LU2328871848.SGD","BK4585","BK1141","BK1574","SG9999014674.SGD","LU1064130708.USD"],"gpt_icon":0},{"id":"2619485826","title":"荣昌生物公布国际专利申请:“抗Claudin18.2抗体药物偶联物用于治疗胃癌和/或胃食管结合部腺癌的用途”","url":"https://stock-news.laohu8.com/highlight/detail?id=2619485826","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619485826?lang=zh_cn&edition=full","pubTime":"2026-03-16 05:02","pubTimestamp":1773608540,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示荣昌生物公布了一项国际专利申请,专利名为“抗Claudin18.2抗体药物偶联物用于治疗胃癌和/或胃食管结合部腺癌的用途”,专利申请号为PCT/CN2025/119274,国际公布日为2026年3月12日。专利详情如下:图片来源:世界知识产权组织今年以来荣昌生物已公布的国际专利申请2个,较去年同期增加了100%。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了6.47亿元,同比减19.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600001455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","688331","LU1064131003.USD","LU1969619763.USD","LU2328871848.SGD","BK1583","LU1064130708.USD","BK1161","LU2488822045.USD","BK0239","LU2148510915.USD","BK1574"],"gpt_icon":0},{"id":"2619928821","title":"智通港股解盘 | 脑机接口概念再起 稳定币牌照发放在即","url":"https://stock-news.laohu8.com/highlight/detail?id=2619928821","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619928821?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:12","pubTimestamp":1773403965,"startTime":"0","endTime":"0","summary":"所有已归属股份均设有长达 5 年的禁售期,同时配套退扣机制、服务绑定等约束机制,强化长期利益绑定。此前,香港特区政府财政司司长陈茂波表示,香港已实施法币稳定币发行人发牌制度,将在3 月发出首批牌照。而目前已进入 3 月中旬,这意味着牌照发放已进入倒计时阶段。公开信息显示,本次金管局共收到 36 个稳定币牌照申请,涉及蚂蚁数科、蚂蚁国际、京东币链科技(香港)、连连数字等多类机构。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1861220207.SGD","ICRC","BK1589","LU0164865239.USD","CRCO","BK1161","BK1110","LU0516422952.EUR","LU0228367735.SGD","LU1064131003.USD","LU1861217088.USD","00883","09995","VXUS","LU0106831901.USD","CRCD","BK4588","BK1202","LU0871576103.HKD","BK4585","01907","LU0149721374.USD","80883","BK1147","LU1064130708.USD","LU1242518931.SGD","LU2360107671.USD","LU1791807156.HKD","BK1610","LU1969619763.USD","LU0979878070.USD","CRCA","LU0516422440.USD","LU0164880469.USD","BK1528","02611","01428","BK4023","BK1521","LU0516422366.SGD","LU2148510915.USD","BK1583","LU0516423091.SGD","LU0531971595.HKD","BK1238","CCUP","LU0039217434.USD"],"gpt_icon":1},{"id":"2619551156","title":"港股异动 | 荣昌生物(09995)再涨超5% RC288注射液上市申请获受理 机构看好其全球潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2619551156","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619551156?lang=zh_cn&edition=full","pubTime":"2026-03-13 11:09","pubTimestamp":1773371354,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,荣昌生物再涨超5%,截至发稿,涨4.41%,报90港元,成交额1.52亿港元。消息面上,近日,荣昌生物RC288注射液的上市申请获得NMPA受理。RC288为荣昌生物自主研发的PSMA/B7H3 ADC,临床前期研究中,该药表现出优异的抗肿瘤活性和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4585","688331","VXUS","BK4588","LU1064131003.USD","LU2328871848.SGD","LU2148510915.USD","LU1969619763.USD","BK0239","BK1583","LU1064130708.USD","LU2488822045.USD","BK1161","09995"],"gpt_icon":0},{"id":"2618929922","title":"每日卖空追踪 | 荣昌生物 03月11日卖空量成交15.35万股,卖空比例为3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618929922","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618929922?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217843,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间03月11日,涨1.12%,卖空量成交15.35万股,较上一交易日减少84.63%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163635a6b79756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163635a6b79756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","LU1969619763.USD","LU2328871848.SGD","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2618691980","title":"3月10日荣昌生物涨10.27%,万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618691980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618691980?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:21","pubTimestamp":1773130910,"startTime":"0","endTime":"0","summary":"证券之星消息,3月10日荣昌生物涨10.27%创60日新高,收盘报118.35元,换手率6.81%,成交量11.11万手,成交额12.76亿元。重仓荣昌生物的前十大公募基金请见下表:该股最近90天内共有5家机构给出评级,买入评级4家,增持评级1家;过去90天内机构目标均价为151.81。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共50家,其中持有数量最多的公募基金为万家基金的万家行业优选LOF。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000024262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","160916","LU1064131003.USD","09995","BK1583","LU1969619763.USD","LU2328871848.SGD","LU1064130708.USD","LU2148510915.USD","BK0239","688331","LU2488822045.USD","BK1574"],"gpt_icon":0},{"id":"2618603610","title":"每日卖空追踪 | 荣昌生物 03月09日卖空量成交49.75万股,卖空比例为7.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618603610","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618603610?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045043,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间03月09日,涨0.06%,卖空量成交49.75万股,较上一交易日减少76.55%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163632a45aea63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163632a45aea63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1574","BK1583","09995","LU2328871848.SGD","BK1161"],"gpt_icon":0},{"id":"2618603654","title":"荣昌生物盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618603654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618603654?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:53","pubTimestamp":1773021225,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时53分,荣昌生物股票出现异动,股价大幅下挫5.04%。截至发稿,该股报81.000港元/股,成交量134.25万股,换手率0.64%,振幅4.28%。荣昌生物股票所在的生物技术行业中,整体跌幅为4.20%。其相关个股中,科济药业-B、维立志博-B、轩竹生物-B涨幅较大,振幅较大的相关个股有科济药业-B、派格生物医药-B、维立志博-B,振幅分别为31.19%、15.64%、12.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309095345a6b09d2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309095345a6b09d2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2328871848.SGD","LU1969619763.USD","BK1583","BK1161","09995"],"gpt_icon":0},{"id":"2617698450","title":"荣昌生物:PSMA/B7H3 ADC申报IND正心Ecosphere","url":"https://stock-news.laohu8.com/highlight/detail?id=2617698450","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617698450?lang=zh_cn&edition=full","pubTime":"2026-03-08 20:04","pubTimestamp":1772971440,"startTime":"0","endTime":"0","summary":"2026年3月2日,荣昌生物RC288注射液上市申请获NMPA受理。RC288是荣昌生物自主研发的PSMA/B7H3 ADC,采用TOP1i为payload,通过可裂解linker偶联到抗体,运用定点偶联技术,DAR值为8,临床前期研究显示其抗肿瘤活性优异且安全性良好。在开发纬迪西妥单抗后,荣昌生物建立TOPi ADC技术平台,重点推进CDCP1 ADC、PSMA/B7H3 ADC,前者重点探索结直肠癌、肺癌、乳腺癌适应症,后者重点探索前列腺癌适应症。此外,荣昌生物PD-1/VEGF双抗已推进到三期临床阶段,并与艾伯维达成56亿美元合作开发协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030821171797aa8b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030821171797aa8b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU1969619763.USD","BK1583","LU2328871848.SGD","BK1161","09995"],"gpt_icon":0},{"id":"1151451437","title":"港股异动 | 生物技术板块走强,药捷安康暴涨35%,百奥赛图涨14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151451437","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151451437?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:32","pubTimestamp":1772767952,"startTime":"0","endTime":"0","summary":"圣诺医药涨超11%,荣昌生物、基石药业涨超8%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5137f1e9d165d819bc52e4abac894dbc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","09995","02617","02616","02257"],"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617066845?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势,三生制药 涨9.83%,基石药业-B涨6.84%,荣昌生物涨6.31%,映恩生物-B涨5.98%,四环医药涨5.76%,恒瑞医药涨5.77%,君圣泰医药-B涨5.58%,康诺亚-B涨5.31%,复宏汉霖涨5.02%。交银国际表示,本周各公司业绩预告陆续发布,该机构建议持续关注财务表现超预期、盈利路径清晰的公司,其业绩兑现有望催化板块行情。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK1515","HK0000252160.HKD","BK1593","06978","09995","02616","01276","HK0000165453.HKD","BK1161","BK1600","LU2543165471.USD","02696","BK1574","00460","HK0000320223.HKD","02511","01530","HK0000306701.USD","HK0000252152.HKD","LU0359201612.USD","LU0359201885.HKD","02162","HK0000320264.USD","LU2328871848.SGD","BK1587","LU0359202008.SGD","BK1191","LU1023057109.AUD","HK0000306685.HKD","BK1583","09606","159992","HK0000500386.USD"],"gpt_icon":0},{"id":"2617505041","title":"港股异动 | 荣昌生物(09995)涨超6% 25年股东应占利润7.09亿元 机构料其现金储备显著增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2617505041","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617505041?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:20","pubTimestamp":1772763627,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,荣昌生物涨超6%,截至发稿,涨6.44%,报81.75港元,成交额1.7亿港元。消息面上,近日,荣昌生物发布2025年度业绩快报,该公司取得营业总收入人民币32.51亿元,同比增加89.36%;归属于母公司所有者的净利润人民币7.09亿元,同比扭亏为盈;基本每股收益人民币1.29元。因现金储备显著增加,公司营运支出将按年升28%至35亿元人民币,扭转去年成本节约趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5137f1e9d165d819bc52e4abac894dbc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","BK4588","LU1064130708.USD","688331","VXUS","LU2328871848.SGD","BK1583","BK1161","LU2488822045.USD","VT","BK1574","LU1064131003.USD","LU1969619763.USD","BK0239","BK4585","09995"],"gpt_icon":0},{"id":"2617952321","title":"每日卖空追踪 | 荣昌生物 03月05日卖空量成交9.85万股,卖空比例为2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617952321","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617952321?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699443,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间03月05日,涨7.03%,卖空量成交9.85万股,较上一交易日减少87.26%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163624a6a5dc10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163624a6a5dc10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2328871848.SGD","BK1161","BK1574","LU1969619763.USD","09995"],"gpt_icon":0},{"id":"1125890948","title":"荣昌生物(09995)2026年2月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125890948","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125890948?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:07","pubTimestamp":1772615223,"startTime":"0","endTime":"0","summary":"荣昌生物制药(烟台)股份有限公司于2026年3月4日发布截至2026年2月28日的证券变动月报。报告显示,公司H股与A股在法定/注册股本和已发行股份方面均未发生任何增减变化,股本结构保持稳定。\\n\\n根据公告,H股于2026年2月底的已发行股份数为208,581,239股,与上月底保持一致,且无库藏股份。公司确认截至2026年2月底符合香港联交所对H股最低公众持股量的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"gpt_icon":0},{"id":"2616653681","title":"荣昌生物03月04日遭主力抛售133.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616653681","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616653681?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612105,"startTime":"0","endTime":"0","summary":"03月04日, 荣昌生物股价跌1.98%,报收71.85元,成交金额2.6亿元,换手率1.76%,振幅5.53%,量比1.25。荣昌生物今日主力资金净流出133.5万元,连续3日净流出,上一交易日主力净流出256.6万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为3.51%。该股近5个交易日下跌9.82%,主力资金累计净流出687.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1167.8万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161513a6a138a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161513a6a138a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1574","LU2328871848.SGD","BK1161","BK1583","09995"],"gpt_icon":0},{"id":"2616350045","title":"中国Biotech,何时能盈利?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350045","media":"药通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616350045?lang=zh_cn&edition=full","pubTime":"2026-03-04 15:31","pubTimestamp":1772609513,"startTime":"0","endTime":"0","summary":"不止荣昌生物,经过市场与时间的双重锤炼,一批Biotech已走出阵痛期,亏损成为过去式。和铂医药是国内Biotech BD交易的典范,无论是传统license out还是NewCo,亦或是技术平台合作,和铂医药都已是信手拈来。中国Biotech何时能盈利?因此投资人也需要给予Biotech们一些耐心和信心。众多Biotech谁能在时代的浪潮中脱颖而出,让我们拭目以待。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603041608299542f0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603041608299542f0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09995","06978","LU1969619763.USD","09969","LU2328871848.SGD","BK1583","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0495},{"period":"1month","weight":0.1542},{"period":"3month","weight":0.1903},{"period":"6month","weight":-0.103},{"period":"1year","weight":3.3248},{"period":"ytd","weight":0.2944}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药(烟台)股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.007165},{"month":4,"riseRate":0.8,"avgChangeRate":0.104301},{"month":5,"riseRate":0.4,"avgChangeRate":-0.023394},{"month":6,"riseRate":0.8,"avgChangeRate":0.127757},{"month":7,"riseRate":0.6,"avgChangeRate":-0.032319},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}